avapro / avalide recovery plan

12
Avapro / Avalide Recovery Plan Sales Rep Tools Harrisburg District October 4, 2006 Prepared and delivered by Jim Brown

Upload: betha

Post on 11-Jan-2016

42 views

Category:

Documents


2 download

DESCRIPTION

Avapro / Avalide Recovery Plan. Sales Rep Tools Harrisburg District October 4, 2006 Prepared and delivered by Jim Brown. Plan Premise. Q2 SGA performance favorable Q3-to-date market share and volume performance stabilized with slight improvement - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Avapro / Avalide Recovery Plan

Avapro / Avalide Recovery Plan

Sales Rep ToolsHarrisburg DistrictOctober 4, 2006

Prepared and delivered by Jim Brown

Page 2: Avapro / Avalide Recovery Plan

Plan Premise

• Q2 SGA performance favorable

• Q3-to-date market share and volume performance stabilized with slight improvement

• District Q3 performance behind Region, at bottom of district list

• Diovan and Benicar NRx volume trumps Avapro

Page 3: Avapro / Avalide Recovery Plan

Analysis Methodology

• Keep it simple

• Ensure START call plan adherence

• Increase focus: use Enhanced Rx Report– Found on e-Reports on SFO– Targets VH / H value rated docs

• Integrate MHC payor product access for greatest impact (i.e. Tier 2, available status)

Page 4: Avapro / Avalide Recovery Plan

AVAPRO VH / H prescribers by Territory defined by Enhanced NRx Report

# of targets: Reading = 65, HBG E = 23, HBG N = 49, HBG S = 52, Gettysburg = 32

0

5

10

15

20

25

30

35

% S

har

e

Reading HBG E HBG N HBG S Gettysburg

Brand Share Share of SuperBrand Market Weekly NRx Rpt Territory Share w/e 8/25

Page 5: Avapro / Avalide Recovery Plan

AVALIDE VH / H prescribers by Territory defined by Enhanced NRx Report

# of targets: Reading = 65, HBG E = 26, HBG N = 41, HBG S = 50, Gettysburg = 41

0

5

10

15

20

25

30

35

40

45

% S

har

e

Reading HBG E HBG N HBG S Gettysburg

Brand Share Share of SuperBrand Market Weekly NRx Rpt Territory Share w/e 8/25

Page 6: Avapro / Avalide Recovery Plan

This report provides focused sorting and targeting of highest value targetsusing 12 Wk NRx Brand and Market Volumes

(Note: Market volume reflects SuperBrand scripts)(Note worksheet tabs: all products are included in this report)

Page 7: Avapro / Avalide Recovery Plan

Sort targets using the AutoSort arrow for the respective column of interest

Page 8: Avapro / Avalide Recovery Plan

Zip Code

Rating

(VH,H Only) Prescriber

Primary Specialty

12 Wk NRx Brand Vol

12 Wk NRx Market Vol

    TERRITORY TOTAL 834 10,366

17356 H DEHART, DRAKE PC 11 153

17011 H GUSTAVSON, ROGER IM 1 94

17011 H FRANTZ, KATHRYN IM 0 89

17344 VH HESS, RUSSELL PC 8 82

17331 VH LUNSFORD, JOHN PC 11 74

17403 VH GLORIOSO, ROBERT PC 1 72

17011 H EHGARTNER, GREGORY IM 0 71

17313 VH KRESGE, DALE IM 4 71

17402 H BRADLEY, CRAIG PC 1 67

17011 H CONNER, KENNETH IM 3 66

17331 H PECK, MICHAEL PC 1 65

17403 H BEEKEY, CYRUS IM 7 64

• Hide irrelevant columns in Report for side-by-side NRx and Market Volume comparison to reveal doc-by-doc potential.• Integrate MHC payor status by practice to proactively eliminate “cost” objection.• Remember, Market Vol. reflects SuperBrand, not ARB or ARB/HCT individual markets.

Example: HBG S., top 12 market potential docs, average at least 5 market NRx/Week.Look at brand potential!

Page 9: Avapro / Avalide Recovery Plan

Next Steps• Use CallMax queries and Excel analysis to

target remaining brand & superbrand potential, that is, M, L, VL rated docs representing the following business spread in the HBG District:

M, L, VL Docs Remaining

Brand Share

M, L, VL Docs Remaining

Share of Market

Avapro 65-85% 75-87%

Avalide 58-80% 68-86%

Page 10: Avapro / Avalide Recovery Plan

Next Steps

• Capture MHC payor prevalence by territory, followed by tops docs sorting by payor, for focused MHC messaging execution. (see examples)

• Create MHC status grid for Avapro / Avalide and competitors for rep training.

Page 11: Avapro / Avalide Recovery Plan

MHC Plan / Payor Prevalence in BMS HBG South TerritoryBased on 26 Weeks of CallMax NRx Data, 353 Prescribers, thru June 2006

0

500

1000

1500

2000

2500

MH

C P

lan

Pre

va

len

ce

Cu

mu

lati

ve

NR

x V

olu

me

%

Page 12: Avapro / Avalide Recovery Plan

PACE

Last Name First Name City (Primary) Zip AVP NRx AVL NRx Diovan NRx Benicar NRx PACE (PA)

ALEXANDROV MARIA HANOVER 17331 0 5 0 1 28

SCARITO ELIZABETH YORK 17402 3 5 1 0 26

HENDERSON CAROL YORK 17402 0 0 0 0 25

JACOBUS PAULA YORK 17402 3 6 25 6 24

MILLS JAMES YORK 17403 0 0 4 0 23

FREER LAWRENCE HANOVER 17331 3 0 5 1 21

TESTA DONNA YORK 17403 0 0 12 0 21

WOERTHWEIN KENNETH YORK 17404 6 3 37 3 21

DEPAMPHILIS HY HANOVER 17331 5 3 23 0 20

HEIRD STEVEN YORK 17403 0 0 0 0 20

MAHMUD RIFFAT SHREWSBURY 17361 2 4 16 11 20

MANZELLA JOHN YORK 17405 10 7 32 0 20

NICHOLSON W YORK 17403 0 0 0 0 20

SIDDIQUI KHALID HANOVER 17331 1 0 11 0 20

CARPENTER CATHY YORK 17403 9 3 26 2 19

GARCIA MICHAEL HANOVER 17331 7 0 4 5 19

LYND CLIFFORD YORK 17403 0 0 0 0 19

MANNING CATHY YORK 17403 10 1 17 7 19

MATHEWS RAYMOND HANOVER 17331 5 10 18 5 19

TALLURI SATISH YORK 17403 6 0 9 9 19

GEISELMAN DOUGLAS YORK 17404 7 6 0 1 18

% Volume of NRx Scripts